Navigation Links
Cannabis linked to earlier onset of psychosis
Date:2/8/2011

A new study has provided the first conclusive evidence that cannabis use significantly hastens the onset of psychotic illnesses during the critical years of brain development with possible life-long consequences.

The first ever meta-analysis of more than 20,000 patients shows that smoking cannabis is associated with an earlier onset of psychotic illness by up to 2.7 years.

The analysis, by an international team including Dr Matthew Large, from the University of New South Wales (UNSW) School of Psychiatry and Sydney's Prince of Wales Hospital, is published today in the prestigious journal Archives of General Psychiatry.

In partnership with St Vincent's Hospital and The George Washington University School of Medicine and Health Sciences, the study set out to establish the extent to which use of cannabis, alcohol and other psychoactive substances affects the age at onset of psychotic illnesses such as schizophrenia.

Cannabis is the most widely used illicit drug in Australia with 33.5% of the population reporting use at some time, according to the 2007 National Drug Household Survey. Some 18% of all secondary school students aged 12-17 reported using the drug at some time in their life, according to the 2004 Secondary School Survey. (UNSW's National Cannabis Prevention and Information Centre http://ncpic.org.au/)

Building on several decades of research, the finding is an important breakthrough in the understanding of the relationship between cannabis use and psychosis, Dr Large said.

A number of previous studies have found an association between psychosis and the use of cannabis, alcohol and other psychoactive substances. However, the aim of this study was to specifically show the extent to which this is caused by cannabis use alone, he said.

The current findings support the view that cannabis use precipitates schizophrenia and other psychotic disorders, perhaps through an interaction between genetic and environmental disorders or by disrupting brain development, the team notes.

"The study re-analysed the results from 20,000 patients with schizophrenia or other psychotic illnesses from 83 previous studies. The study used meta-analysis a modern statistical method to show that an earlier onset of severe mental illness among substance users is a result of cannabis use, and cannot be explained by other factors such as alcohol use," Dr Large said.

"Results of this study are conclusive and clarify previously conflicting evidence of a relationship between cannabis use and the earlier onset of a psychotic illness, with evidence supporting the theory that cannabis use plays a causal role in the development of psychosis in some patients."

Dr Large said there was a high prevalence of substance use among individuals treated in mental health settings, and patients with schizophrenia were more likely to use substances than members of the wider community.

"The results of this study provide strong evidence that stopping or reducing cannabis use could delay or even prevent some cases of psychosis.

"The study raises the question of whether those substance users would still have gone on to develop psychosis a few years later.

"However, even if the onset of psychosis were inevitable, an extra two or three years of psychosis-free functioning could allow many patients to achieve important developmental milestones of late adolescence and early adulthood that could lower long-term disability arising from psychotic disorders," Dr Large said.

"The results of this study confirm the need for an ongoing public health warning about the potentially harmful effects of cannabis."


'/>"/>

Contact: Steve Offner
s.offner@unsw.edu.au
61-424-580-208
University of New South Wales
Source:Eurekalert

Related biology news :

1. Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia
2. Weeding out marijuana: Researchers close in on engineering recognizable, drug-free Cannabis plant
3. Breast cancer treatment resistance linked to signaling pathway
4. Lack of vitamin D linked to Parkinsons disease
5. Resveratrol, red wine compound linked to health, also found in dark chocolate and cocoa
6. Racial disparities in cardiovascular health linked to birth weight, slavery
7. Geologist who linked cosmic strike to dinosaurs extinction takes top prize
8. Hypertension disparity linked to environment
9. Seasonal affective disorder may be linked to genetic mutation, study suggests
10. Shifts in soil bacterial populations linked to wetland restoration success
11. Hairspray is linked to common genital birth defect, says study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert Technologies, which ... today to pursue the highest level of accuracy and quality with the addition ... and the AR5 Refractometer. Accurate, reliable and tough enough for the most ...
(Date:2/10/2016)... BioAmber Inc. (NYSE: BIOA ), a leader in ... Co. Ltd., its partner in the Sarnia ... additional CDN$25 million in the joint venture for 10% ... 40%.  Mitsui will also play a stronger role in ... Sarnia , providing dedicated resources alongside BioAmber,s commercial ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... (NYSE MKT: ISR), a medical technology company and innovator ... treatment of prostate, brain, lung, head and neck and ... second quarter and six months of fiscal 2016, which ... --> Revenue was $1.19 million for ... 31, 2015, a 12% increase compared to $1.07 million ...
Breaking Biology Technology: